|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Helius Medical Technologies, Inc. (HSDT) |
|
|
$0.18 0.00 (0.00%) as of 4:30 Wed 8/16
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
2,317,000 |
Market
Cap: |
414.74(K) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.151 - $0.2193 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Helius Medical Technologies is a neurotechnology company. Co. develops, licenses or acquires non-implanted technologies targeted at reducing symptoms of neurological disease or trauma. Co.'s primary product, known as the Portable Neuromodulation Stimulator, is authorized for sale in Canada for two indications: for use as a short term treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with physical therapy; and for use as a short term treatment of gait deficit due to mild and moderate symptoms from multiple sclerosis and it is to be used in conjunction with physical therapy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
10,290 |
20,368 |
575,118 |
Total Buy Value |
$0 |
$74,380 |
$144,931 |
$383,368 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
5 |
7 |
16 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Andreeff Dane |
Director |
|
2018-06-25 |
4 |
B |
$10.10 |
$50,500 |
I/I |
5,000 |
791,069 |
2.1 |
- |
|
Griffin Thomas E |
Director |
|
2018-04-13 |
4 |
B |
$7.47 |
$24,995 |
D/D |
3,346 |
3,346 |
2.39 |
- |
|
Sackier Jonathan |
Chief Medical Officer |
|
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
62,002 |
703,403 |
|
- |
|
Tyler Mitch E |
Director |
|
2018-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
829,545 |
829,545 |
|
- |
|
Andreeff Dane |
Director |
|
2017-12-22 |
4 |
B |
$1.96 |
$499,998 |
I/I |
255,101 |
789,435 |
2.1 |
- |
|
Laviscount Joyce N |
CFO and COO |
|
2017-12-22 |
4 |
B |
$1.96 |
$155,001 |
D/D |
79,082 |
129,306 |
2.74 |
- |
|
Walter Blane |
Director |
|
2017-12-22 |
4 |
B |
$1.96 |
$750,000 |
D/D |
382,653 |
422,653 |
2.39 |
- |
|
Deschamps Philippe |
President and CEO |
|
2017-12-22 |
4 |
B |
$1.96 |
$250,000 |
I/I |
127,551 |
3,334,556 |
2.66 |
- |
|
Walter Blane |
Director |
|
2017-11-17 |
4 |
B |
$2.51 |
$50,250 |
D/D |
20,000 |
40,000 |
2.39 |
- |
|
Walter Blane |
Director |
|
2017-11-16 |
4 |
B |
$2.40 |
$48,090 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
Andreeff Dane |
Director |
|
2017-11-13 |
4 |
B |
$2.23 |
$55,625 |
I/I |
25,000 |
706,288 |
2.1 |
- |
|
Andreeff Dane |
Director |
|
2017-11-10 |
4 |
B |
$2.59 |
$212,495 |
I/I |
82,000 |
698,117 |
2.1 |
- |
|
Andreeff Dane |
Director |
|
2017-11-09 |
4 |
B |
$2.70 |
$162,240 |
I/I |
60,000 |
671,317 |
2.1 |
- |
|
Andreeff Dane |
Director |
|
2017-08-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,240,600 |
|
- |
|
Deschamps Philippe |
President and CEO |
|
2016-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
50,186 |
54,886 |
|
- |
|
Bapty Brian |
Vice President |
|
2016-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
332,700 |
|
- |
|
Laviscount Joyce N |
CFO and COO |
|
2016-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
50,224 |
50,224 |
|
- |
|
Lam Kong |
10% Owner |
|
2015-12-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,638,889 |
|
- |
|
Bapty Brian |
Vice PresidentOfficer |
|
2015-11-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
282,700 |
|
- |
|
Straw Edward M |
Director |
|
2015-09-10 |
4 |
B |
$0.80 |
$9,963 |
D/D |
12,500 |
12,500 |
2.39 |
- |
|
Kaczmarek Kurt |
10% Owner |
|
2015-05-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,035,026 |
|
- |
|
Deschamps Philippe |
President and CEOOfficer |
|
2015-05-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,207,005 |
|
- |
|
Deschamps Philippe |
President and CEOOfficer |
|
2015-05-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,700 |
|
- |
|
Advanced Neurorehabilitation, Llc |
10% Owner |
|
2015-05-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,035,026 |
|
- |
|
Mpj Healthcare, Llc |
10% Owner |
|
2015-05-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,035,026 |
|
- |
|
101 Records found
|
|
Page 4 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|